DNP GLOBAL

[HOME]

[ABOUT US]

[PRODUCTS]

[CONTACT US]

[SITEMAP]

Why Theralase?

Theralase Technologies Inc. designs, develops and manufactures patented, super-pulsed laser technology used in a wide range of bio-stimulation and bio-destruction clinical applications. The Theralase technology platform targets several diverse healthcare sectors: firstly, for non-invasive pain management and clinical therapy, in hundreds of neural muscular skeletal conditions, including arthritis; secondly, to bio-stimulate and accelerate wound care and healing, including bone fracture regeneration; and thirdly, combining photodynamic compounds with super-pulsed, biofeedback laser technology to attack specifically targeted cancer, bacteria, viruses and fat cells.

Our highly trained team continuously strives to bring our valued customers the latest technology, superior customer support (technical and marketing) and training, in order to contribute to the success of their practice.

Theralase actively conducts in-depth research into Low Level Laser Therapy, and works closely with leading medical universities and institutions to research and implement the latest findings in the field, into their LLLT machines.

Theralase is FDA, Health Canada, ISO and CSA approved.

Academic Affiliations
Ontario Centers of Excellence
Virginia Polytechnic Institute & State University
University Health Network
James Andrews M.D.
American Sports Medicine Network
Safety Affiliations
U.S. FDA
Health Canada
International Quality Medical Standard ISO 13485:1996
CSA - 601

Low Level Laser Therapy

Theralase, Inc. Canada

How does it work?

Treatment

>

>

Conditions treated

>

>

>

>

>

>

Why Theralase LLLT?

Papers

F.A.Q.